ストックスクリーナーアプリを入手
84.02
1.31%
1.09
前日終値:
$82.93
開ける：
$83.46
24時間の取引高:
2.06M
Relative Volume:
10.26
時価総額：
$16.46B
収益：
$579.96M
当期純損益:
$-729.89M
株価収益率:
-22.43
EPS:
-3.7459
ネットキャッシュフロー:
$-452.02M
1週間 パフォーマンス:
+3.24%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$82.74
$85.30
1週間の範囲:
$80.70
$85.30
52週間の値動き範囲:
$78.98
$85.30
Bio Rad Laboratories Inc Stock (BBIO) Company Profile
Compare BBIO vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BBIO
Bio Rad Laboratories Inc
|
84.02 | 16.46B | 579.96M | -729.89M | -452.02M | -3.7459 |
ABT
Abbott Laboratories
|
103.06 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.25 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.21 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
44.25 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.63 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bio Rad Laboratories Inc (BBIO) 最新ニュース
Bio-Rad Laboratories (BIO) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
Insight Molecular Diagnostics Ord Shs (IMDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bio-Rad Laboratories (BIO) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Bio-Rad Laboratories Inc (BIO) Stock Up 3.4% and Still Undervalued -- GF Score: 72/100 - GuruFocus
Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026 - BioSpace
Press Release: Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026 - Moomoo
Bio-Rad will discuss Q2 results at 5 p.m. ET on Aug. 4 - Stock Titan
Bio-Rad Laboratories stock holds on to year-end earnings context - AD HOC NEWS
Bio-Rad Laboratories (BIO) Experiences Minor Decline Amid Compet - GuruFocus
Bio-Rad Laboratories, Inc. (BIO) Stock Forecasts - Yahoo Finance
Diagnostic Reagent Market is Going to Boom: New Report Reveals - openPR.com
(BIO) Volatility Zones as Tactical Triggers - Stock Traders Daily
ETFs Investing in Bio-Rad Laboratories, Inc. Class A Stocks - TradingView
BIO5368763 Bond Coupon Profile — Rate & Payments - TradingView
BIO5368763 Bond Risk Profile - TradingView
BIO5368763 Bond Profile — Key Metrics - TradingView
BIO5368765 Bond Profile — Key Metrics - TradingView
BIO5368765 Bond Coupon Profile — Rate & Payments - TradingView
Bio-Rad unveils Vericheck ddPCR kits for QX700 QC - Select Science
Price to earnings forward of Bio-Rad Laboratories, Inc. – NYSE:BIO - TradingView
Bio Rad Laboratories (BIO) Launches New ddPCR Kits Following A Fair Value Debate - Sahm
Is It Too Late to Buy Bio-Rad Laboratories Inc (BIO) After 4.7% Rally? GF Value Says Undervalued - GuruFocus
Bio-Rad launches Vericheck ddPCR Kits compatible with QX700 platform for biopharma quality control and cell and gene therapy workflows - News-Medical
Bio-Rad Releases New Quality Control Kits for Cell and Gene Therapy - Clinical Lab Products
IVD Quality Control Market Size, Share | Industry Report [2034] - Fortune Business Insights
Bio-Rad: Activist Involvement Highlights Value-Unlocking Potential (NYSE:BIO) - Seeking Alpha
BIO Forecast — Price Target — Prediction for 2027 - TradingView
Price-Driven Insight from (BIO) for Rule-Based Strategy - Stock Traders Daily
2x Valuation Gap: BIO vs. CRL — Who’s Wrong? - NAI500
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026? - Yahoo Finance
In Fight With GC, Bio-Rad Adds Quinn Emanuel to Legal Team - Law.com
Bio-Rad Receives MicroVal Validation for Two EZ-Check Listeria Testing Kits - Quality Assurance & Food Safety
Bio-Rad receives microVal validation for EZ-CheckTM Listeria spp. and EZ-Check Listeria monocytogenes Testing Kits - Cambridge Network
Bio-Rad Laboratories (BIO) Surges 4.4% as Bullish Momentum Builds From Key Support LevelOBV Divergence - dars.gov.et
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating the Medical Device Terrain with a 3.22% Upside - DirectorsTalk Interviews
Elliott Targets Bio-Rad After 70% Stock Collapse - Yahoo Finance
Elliott Stake Puts Bio-Rad Turnaround Plans And Sartorius Holding In Focus - Sahm
Elliott builds big stake in life-science firm Bio-Rad Labs, WSJ reports - MSN
Toyo Posts Upbeat Q1 Earnings, Joins Brady, Dominion Energy And Other Big Stocks Moving Higher On Monday - Benzinga
Activist Elliott Investment Management Has Built A Sizable Stake In Bio-Rad Laboratories- WSJ - TradingView
Bio-Rad Expands Antibody Labeling Kits for Flow Cytometry and Western Blot - Clinical Lab Products
Morgan Stanley files Rule 144 notice to sell 550 BIO shares (NYSE: BIO) - Stock Titan
Bio‑Rad expands TrailBlazer kits for antibody conjugation to StarBright dyes - Select Science
Bio-Rad to Participate in Upcoming Investor ConferencesMay 8, 2026 - BioSpace
Ariel Investments Re-added Bio-Rad Laboratories (BIO) as Strong Margins and Market Leadership Stand Out - Yahoo Finance
Bio-Rad Navigates Academic Headwinds and Geopolitical Shifts in Q1 2026 Financial Results - Lab Manager
Unlocking Bio-Rad (BIO) International Revenues: Trends, Surprises, and Prospects - Yahoo Finance
Bio-Rad drops 10.2% as guidance cut and Sartorius valuation hit overshadow Q1 results - Quiver Quantitative
Bio-Rad introduces the PTC Harmony 96 and PTC Harmony Deepwell thermal cyclers - Select Science
Liquidity Mapping Around (BIO) Price Events - Stock Traders Daily
Bio-Rad launches PTC Harmony 96 and PTC Harmony Deepwell Thermal Cyclers - News-Medical
Bio Rad Laboratories Inc (BBIO) 財務データ
収益
当期純利益
現金流量
EPS
1.90%
2.27%
大文字化:
|
ボリューム (24 時間):